Masimo Shares Outstanding 2011-2025 | MASI
Masimo shares outstanding history from 2011 to 2025. Shares outstanding can be defined as the number of shares held by shareholders (including insiders) assuming conversion of all convertible debt, securities, warrants and options. This metric excludes the company's treasury shares.
- Masimo shares outstanding for the quarter ending September 30, 2025 were 0.054B, a 0.18% increase year-over-year.
- Masimo 2024 shares outstanding were 0.053B, a 1.48% decline from 2023.
- Masimo 2023 shares outstanding were 0.054B, a 1.99% decline from 2022.
- Masimo 2022 shares outstanding were 0.055B, a 4.33% decline from 2021.
|
Masimo Annual Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2024 | 53 |
| 2023 | 54 |
| 2022 | 55 |
| 2021 | 58 |
| 2020 | 58 |
| 2019 | 57 |
| 2018 | 56 |
| 2017 | 56 |
| 2016 | 53 |
| 2015 | 54 |
| 2014 | 56 |
| 2013 | 57 |
| 2012 | 58 |
| 2011 | 61 |
| 2010 | 61 |
|
Masimo Quarterly Shares Outstanding (Millions of Shares) |
|
|---|---|
| 2025-09-30 | 54 |
| 2025-06-30 | 55 |
| 2025-03-31 | 55 |
| 2024-12-31 | 53 |
| 2024-09-30 | 54 |
| 2024-06-30 | 54 |
| 2024-03-31 | 54 |
| 2023-12-31 | 54 |
| 2023-09-30 | 54 |
| 2023-06-30 | 54 |
| 2023-03-31 | 54 |
| 2022-12-31 | 55 |
| 2022-09-30 | 54 |
| 2022-06-30 | 55 |
| 2022-03-31 | 57 |
| 2021-12-31 | 58 |
| 2021-09-30 | 58 |
| 2021-06-30 | 57 |
| 2021-03-31 | 58 |
| 2020-12-31 | 58 |
| 2020-09-30 | 58 |
| 2020-06-30 | 58 |
| 2020-03-31 | 58 |
| 2019-12-31 | 57 |
| 2019-09-30 | 57 |
| 2019-06-30 | 57 |
| 2019-03-31 | 57 |
| 2018-12-31 | 56 |
| 2018-09-30 | 56 |
| 2018-06-30 | 56 |
| 2018-03-31 | 55 |
| 2017-12-31 | 56 |
| 2017-09-30 | 56 |
| 2017-06-30 | 56 |
| 2017-03-31 | 56 |
| 2016-12-31 | 53 |
| 2016-09-30 | 54 |
| 2016-06-30 | 53 |
| 2016-03-31 | 52 |
| 2015-12-31 | 54 |
| 2015-09-30 | 54 |
| 2015-06-30 | 54 |
| 2015-03-31 | 54 |
| 2014-12-31 | 56 |
| 2014-09-30 | 55 |
| 2014-06-30 | 57 |
| 2014-03-31 | 58 |
| 2013-12-31 | 57 |
| 2013-09-30 | 57 |
| 2013-06-30 | 57 |
| 2013-03-31 | 58 |
| 2012-12-31 | 58 |
| 2012-09-30 | 58 |
| 2012-06-30 | 58 |
| 2012-03-31 | 59 |
| 2011-12-31 | 61 |
| 2011-09-30 | 61 |
| 2011-06-30 | 61 |
| 2011-03-31 | 61 |
| 2010-12-31 | 61 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Instruments Manufacturing | $7.690B | $2.094B |
| Masimo Corporation develops, manufactures and markets a family of non-invasive monitoring systems. The Company has two segments: Product Revenues, Royalty & Other revenues. Within Product revenues, the company's flagship - Signal Extraction Tecgnology (SET) Pulse Oximetry - is used to monitor blood oxygen saturation levels and protect against hypoxemia and hyperoxemia. The device also measures pulse rate. Apart from blood monitoring, the company has also ventured into non-invasive blood constituent, brain and breathe monitoring. The company's rainbow Pulse CO-Oximetry measures blood constituents that include total hemoglobin (SpHb), oxygen content (SpOC), carboxyhemoglobin (SpCO), methemoglobin (SpMet) and SET measurements of oxygen saturation (SpO2), pulse rate (PR), perfusion index (PI), and pleth variability index (PVi). Rainbow Acoustic Monitoring measures respiration rate (RRa) non-invasively and on a continuous basis. SedLine monitors brain functioning of patients under anesthesia or sedation. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Thermo Fisher Scientific (TMO) | United States | $215.059B | 25.55 |
| Intuitive Surgical (ISRG) | United States | $200.747B | 78.54 |
| IDEXX Laboratories (IDXX) | United States | $56.571B | 56.18 |
| Edwards Lifesciences (EW) | United States | $48.391B | 32.45 |
| Alcon (ALC) | Switzerland | $36.485B | 24.49 |
| IQVIA Holdings (IQV) | United States | $35.841B | 19.99 |
| Mettler-Toledo (MTD) | United States | $29.649B | 34.40 |
| STERIS (STE) | Ireland | $25.888B | 26.72 |
| Waters (WAT) | United States | $22.128B | 29.27 |
| DexCom (DXCM) | United States | $21.451B | 29.57 |
| Hologic (HOLX) | United States | $16.481B | 17.35 |
| SONOVA HOLDING (SONVY) | Switzerland | $15.721B | 0.00 |
| Globus Medical (GMED) | United States | $11.330B | 23.57 |
| Penumbra (PEN) | United States | $10.425B | 73.33 |
| Sysmex ADR (SSMXY) | Japan | $6.698B | 21.28 |
| Teleflex (TFX) | United States | $4.835B | 7.70 |
| Glaukos (GKOS) | United States | $4.816B | 0.00 |
| TransMedics (TMDX) | United States | $4.073B | 48.25 |
| Veracyte (VCYT) | United States | $3.296B | 37.57 |
| Alphatec Holdings (ATEC) | United States | $2.941B | 0.00 |
| LivaNova (LIVN) | United Kingdom | $2.755B | 14.88 |
| Integer Holdings (ITGR) | United States | $2.392B | 11.23 |
| Artivion (AORT) | United States | $2.117B | 97.54 |
| Nihon Kohden (NHNKY) | Japan | $2.067B | 24.67 |
| PROCEPT BioRobotics (PRCT) | United States | $1.784B | 0.00 |
| Elekta AB (EKTAY) | Sweden | $1.686B | 16.34 |
| Beta Bionics (BBNX) | United States | $1.158B | 0.00 |
| Tandem Diabetes Care (TNDM) | United States | $1.099B | 0.00 |
| AxoGen (AXGN) | United States | $1.087B | 0.00 |
| IRadimed (IRMD) | United States | $1.073B | 51.11 |
| Pulse Biosciences (PLSE) | United States | $1.048B | 0.00 |
| OPKO Health (OPK) | United States | $1.029B | 0.00 |
| Integra LifeSciences Holdings (IART) | United States | $0.938B | 5.08 |
| SiBone (SIBN) | United States | $0.680B | 0.00 |
| ORTHOFIX MEDICAL INC (OFIX) | United States | $0.591B | 0.00 |
| Tactile Systems Technology (TCMD) | United States | $0.555B | 32.29 |
| Pacific Biosciences Of California (PACB) | United States | $0.529B | 0.00 |
| AVANOS MEDICAL, INC (AVNS) | United States | $0.521B | 10.40 |
| AngioDynamics (ANGO) | United States | $0.495B | 0.00 |
| ClearPoint Neuro (CLPT) | United States | $0.449B | 0.00 |
| NeuroPace (NPCE) | United States | $0.437B | 0.00 |
| OrthoPediatrics (KIDS) | United States | $0.427B | 0.00 |
| Mesa Laboratories (MLAB) | United States | $0.418B | 11.59 |
| Semler Scientific (SMLR) | United States | $0.418B | 3.28 |
| RxSight (RXST) | United States | $0.385B | 0.00 |
| Alpha Tau Medical (DRTS) | Israel | $0.327B | 0.00 |
| Delcath Systems (DCTH) | United States | $0.305B | 50.82 |
| Sight Sciences (SGHT) | United States | $0.305B | 0.00 |
| Spectral Diagnostics (EDTXF) | Canada | $0.294B | 0.00 |
| Treace Medical Concepts (TMCI) | United States | $0.282B | 0.00 |
| 908 Devices (MASS) | United States | $0.265B | 0.00 |
| CVRx (CVRX) | United States | $0.255B | 0.00 |
| Inogen (INGN) | United States | $0.189B | 0.00 |
| Neuronetics (STIM) | United States | $0.156B | 0.00 |
| Lucid Diagnostics (LUCD) | United States | $0.144B | 0.00 |
| Anteris Technologies Global (AVR) | Australia | $0.144B | 0.00 |
| Microbot Medical (MBOT) | United States | $0.138B | 0.00 |
| Rapid Micro Biosystems (RPID) | United States | $0.137B | 0.00 |
| Accuray (ARAY) | United States | $0.133B | 0.00 |
| LENSAR (LNSR) | United States | $0.127B | 0.00 |
| Atossa Genetics (ATOS) | United States | $0.106B | 0.00 |
| Zomedica (ZOMDF) | United States | $0.094B | 0.00 |
| Hyperfine (HYPR) | United States | $0.084B | 0.00 |
| QT Imaging Holdings (QTIH) | United States | $0.077B | 0.00 |
| EDAP TMS S.A (EDAP) | France | $0.076B | 0.00 |
| InspireMD (NSPR) | United States | $0.076B | 0.00 |
| Sensus Healthcare (SRTS) | United States | $0.069B | 0.00 |
| Spectral AI (MDAI) | United States | $0.060B | 0.00 |
| Positron (POSC) | United States | $0.051B | 0.00 |
| Baird Medical Investment Holdings (BDMD) | $0.038B | 0.00 | |
| Precision Optics (POCI) | United States | $0.032B | 0.00 |
| DarioHealth (DRIO) | United States | $0.028B | 0.00 |
| Vicarious Surgical (RBOT) | United States | $0.026B | 0.00 |
| NexGel (NXGL) | United States | $0.020B | 0.00 |
| Envoy Medical (COCH) | United States | $0.018B | 0.00 |
| Adagio Medical Holdings (ADGM) | United States | $0.014B | 0.00 |
| EnVVeno Medical (NVNO) | United States | $0.013B | 0.00 |
| Ekso Bionics Holdings (EKSO) | United States | $0.012B | 0.00 |
| Inspira Technologies OXY B.H.N (IINN) | Israel | $0.012B | 0.00 |
| SINTX TECHNOLOGIES, INC (SINT) | United States | $0.012B | 0.00 |
| Tenon Medical (TNON) | United States | $0.010B | 0.00 |
| Check-Cap (CHEK) | Israel | $0.010B | 0.00 |
| PAVmed (PAVM) | United States | $0.009B | 0.00 |
| Solana (HSDT) | United States | $0.006B | 0.00 |
| Autonomix Medical (AMIX) | United States | $0.005B | 0.00 |
| Nanovibronix (NAOV) | United States | $0.005B | 0.00 |
| ENDRA Life Sciences (NDRA) | United States | $0.004B | 0.00 |
| Bluejay Diagnostics (BJDX) | United States | $0.003B | 0.00 |
| Venus Concept (VERO) | Canada | $0.003B | 0.00 |
| Nuwellis (NUWE) | United States | $0.003B | 0.00 |
| WORK Medical Technology Group (WOK) | China | $0.002B | 0.00 |
| Fresenius Medical Care AG KGaA (FMS) | Germany | $0.000B | 11.54 |
| Longview Acquisition II (LGV) | United States | $0.000B | 0.00 |
| Spinal Elements Holdings (SPEL) | United States | $0.000B | 0.00 |